Multi-Center Outcome Analysis of 16 Face Transplantations – A Retrospective OPTN Study
Transplant International · 29.01.2025 · 38
DOI: 10.3389/ti.2025.14107 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transplant International, online erschienen am 29.01.2025. Verfasst von Leonard Knoedler und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universitä…. Hauptthemen laut MEDLINE: Facial Transplantation, Vascularized Composite Allotransplantation. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Facial Vascularized Composite Allotransplantation (fVCA) restores form and function for patients with severe facial disfigurements, yet multi-center outcome data remain scarce. We accessed the Organ Procurement and Transplantation Network (OPTN) database from 2008 to 2024 to identify all full- or partial-face fVCA recipients, excluding patients under 18 years and those with physiologically impossible BMIs. Of 25 identified patients, 16 (64%) met inclusion criteria (69% male; mean age 43 ± 14 years). Recipients experienced a median of 5 [IQR 0.0–10] acute rejection episodes, which correlated with inotrope use during donor procurement (p = 0.033). On average, patients were hospitalized 2.4 ± 1.8 times, with arginine vasopressin (AVP) administration linked to fewer hospitalizations (p = 0.035). Seven recipients (44%) experienced complications, and extended-criteria donor (ECD) status was associated with higher complication rates (p = 0.049). These findings underscore the promise of fVCA to address complex facial defects while identifying key risk factors—particularly inotrope use and ECD status, while AVP administration may mitigate hospital stays. Further studies with larger cohorts are warranted to refine perioperative strategies, improve outcomes, and expand the clinical utility of fVCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
- Department of Hand, Plastic and Reconstructive Surgery, Burn Center, BG Trauma Hospital Ludwigshafen, University of Heidelberg, Ludwigshafen, Germany.
- Department of Plastic and Hand Surgery, Burn Center, BG Trauma Hospital Ludwigshafen, University of Heidelberg, Ludwigshafen, Germany.
- Vascularized Composite Allotransplantation Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
- Shriners Children's Boston, Boston, MA, United States.
- Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Zitieren
APA
Knoedler, L., Schaschinger, T., Niederegger, T., Hundeshagen, G., Panayi, A. C., Cetrulo, C. L., Jeljeli, M., Hofmann, E., Heiland, M., Koerdt, S., & Lellouch, A. G. (2025). Multi-Center Outcome Analysis of 16 Face Transplantations – A Retrospective OPTN Study. Transplant International, 38. https://doi.org/10.3389/ti.2025.14107
Vancouver
Knoedler L, Schaschinger T, Niederegger T, Hundeshagen G, Panayi AC, Cetrulo CL, et al. Multi-Center Outcome Analysis of 16 Face Transplantations – A Retrospective OPTN Study. Transplant International. 2025;38. doi:10.3389/ti.2025.14107
BibTeX
@article{Knoedler2025,
author = {Knoedler, Leonard and Schaschinger, Thomas and Niederegger, Tobias and Hundeshagen, Gabriel and Panayi, Adriana C and Cetrulo, Curtis L and Jeljeli, Maxime and Hofmann, Elena and Heiland, Max and Koerdt, Steffen and Lellouch, Alexandre G},
title = {Multi-Center Outcome Analysis of 16 Face Transplantations – A Retrospective OPTN Study},
journal = {Transplant International},
year = {2025},
volume = {38},
doi = {10.3389/ti.2025.14107}
}
EUVIMED